These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25319272)

  • 1. Opioids prescription for symptoms relief and the impact on respiratory function: updated evidence.
    López-Saca JM; Centeno C
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):383-90. PubMed ID: 25319272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids?
    Clemens KE; Quednau I; Klaschik E
    J Palliat Med; 2008 Mar; 11(2):204-16. PubMed ID: 18333735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
    Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
    J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
    Varkey B
    Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
    Clemens KE; Klaschik E
    J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
    Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
    Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
    Afolabi TM; Nahata MC; Pai V
    Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inhaled opioids and furosemide for the treatment of dyspnea.
    Kallet RH
    Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence?
    Hochgerner M; Fruhwald FM; Strohscheer I
    Wien Med Wochenschr; 2009 Dec; 159(23-24):577-82. PubMed ID: 20151346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
    Currow DC; McDonald C; Oaten S; Kenny B; Allcroft P; Frith P; Briffa M; Johnson MJ; Abernethy AP
    J Pain Symptom Manage; 2011 Sep; 42(3):388-99. PubMed ID: 21458217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids, respiratory function, and dyspnea.
    LeGrand SB; Khawam EA; Walsh D; Rivera NI
    Am J Hosp Palliat Care; 2003; 20(1):57-61. PubMed ID: 12568438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].
    Ficker JH; Brückl WM
    Pneumologie; 2019 Jul; 73(7):430-438. PubMed ID: 31291670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids for refractory dyspnea.
    Mahler DA
    Expert Rev Respir Med; 2013 Apr; 7(2):123-34; quiz 135. PubMed ID: 23547989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nebulized and intranasal opioids for the relief of breathlessness.
    Bausewein C; Simon ST
    Curr Opin Support Palliat Care; 2014 Sep; 8(3):208-12. PubMed ID: 25004175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care.
    Gomutbutra P; O'Riordan DL; Pantilat SZ
    J Pain Symptom Manage; 2013 May; 45(5):885-91. PubMed ID: 22940561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review.
    Vargas-Bermúdez A; Cardenal F; Porta-Sales J
    J Pain Palliat Care Pharmacother; 2015; 29(4):341-52. PubMed ID: 26523974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Datla S; Dirksen CD; Johnson MJ; van Kuijk SMJ; Wouters EFM; Janssen DJA
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29167300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
    Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
    J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.